Home > Insider Trading > Filing (0001144204-12-000308)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1114220	Keryx Biopharmaceuticals Inc	KERX	Pharmaceutical Preparations (2834)	134087132

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1251213	Ron Bentsur	C/O Keryx Biopharmaceuticals, Inc. 750 Lexington Avenue New York NY 10022	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-01-02	33,000	$0.00	392,281	No	4	A	Direct
Common Stock	Disposition	2012-01-03	3,305	$2.63	388,976	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Options (Right to Buy)	Acquisiton	2012-01-02	67,000	$0.00	67,000	$2.53

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
67,000	2013-01-02	2022-01-02	No	4	A	Direct

Footnotes

The 33,000 shares are restricted common stock, with one-third of the 33,000 shares vesting on January 2, 2013, and one-twelfth vesting on each of April 2, 2013, July 2, 2013, October 2, 2013, January 2, 2014, April 2, 2014, July 2, 2014, October 2, 2014, and January 2, 2015.
Of the 392,281 shares, 216,334 are shares of restricted stock.
Sale of a total of 3,305 shares of common stock was made in order to satisfy Mr. Bentsur's income tax withholding obligation upon the vesting of 8,333 shares of restricted stock on January 2, 2012. Mr. Bentsur had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
Of the 388,976 shares, 216,334 are shares of restricted stock.
The options will vest according to the following schedule: one-third of the 67,000 options will vest on January 2, 2013, and one-twelfth will vest on each of April 2, 2013, July 2, 2013, October 2, 2013, January 2, 2014, April 2, 2014, July 2, 2014, October 2, 2014, and January 2, 2015.